Get startedLog in
    Picture of Sanofi SA logo

    SNY — Sanofi SA Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareConservativeLarge CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Sanofi SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

    C2019
    December 31st
    C2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line2,75412,2946,2238,3715,400
    Depreciation
    Deferred Taxes
    Non-Cash Items-293-8,001-10520272
    Discontinued Operations
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-419-3251,409-707764
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Net Change in Other Assets & Liabilities
    Cash from Operating Activities7,7157,41810,52210,52610,258
    Capital Expenditures-1,787-2,083-2,043-2,201-3,024
    Purchase of Fixed Assets
    Other Investing Cash Flow Items7585,702-5,255126-3,176
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-1,0293,619-7,298-2,075-6,200
    Financing Cash Flow Items-21-44-48-99-64
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-4,193-6,485-7,056-5,821-8,052
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash2,5024,488-3,8172,638-4,026